Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on May 15, 2025

Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates
- Duchenne (SGT-003): Participant dosing ongoing in the Phase 1/2 INSPIRE DUCHENNE trial; Solid on track to discuss accelerated pathways with U.S. FDA later in 2025 - - FA (SGT-212): Dosing of first participant anticipated in the second half of 2025 - - …

READI Collect Expands to Over 1,100 Collectors Nationwide and Launches Version 2.0 of Its Industry-Leading App
WILMINGTON, DE, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- READI Collect, a pioneer in mobile drug and alcohol testing solutions, proudly announces two significant milestones: the expansion of its mobile collector network to over 1,100 certified …

Carccu® Recognized as Key Innovator in PFAS-Free Food Packaging Market
SASTAMALA, PIRKANMAA, FINLAND, May 15, 2025 /EINPresswire.com/ -- The global transition toward safer materials has accelerated the rise of PFAS-free food packaging — and Carccu® is playing a vital role in shaping this new direction. Cited by Grand View …

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Emrosi™ commercial launch initiated for the treatment of inflammatory lesions of rosacea in adults Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; special meeting of Checkpoint stockholders to approve the transaction to take place …

Park Aerospace Corp. Reports Fourth Quarter and Fiscal Year Results
NEWTON, Kan., May 15, 2025 (GLOBE NEWSWIRE) -- Park Aerospace Corp. (NYSE-PKE) reported results for the 2025 fiscal year fourth quarter and full fiscal year ended March 2, 2025. The Company will conduct a conference call to discuss its financial results …

Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients Additional Research Includes Acromegaly Symptom Burden and Standard-of-Care Discontinuation Rates SAN DIEGO, …

Birchtech Reports First Quarter 2025 Financial Results
First Quarter 2025 Revenues Totaled $3.2 Million, With Gross Margins Increasing 350 bps to 38.3% CORSICANA, Texas, May 15, 2025 (GLOBE NEWSWIRE) -- Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) ("Birchtech" or the "Company"), a leader in specialty activated …

Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights
– 446 participants completed the brilaroxazine long-term open-label extension (OLE) trial with 156 completing one-year and 301 completing six months of treatment – – Full data set from RECOVER OLE highlighting clinical response, safety, efficacy, adherence …

PLBY Group Reports First Quarter 2025 Financial Results
Q1 Revenue of $28.9 Million, Net Loss of $9.0 Million, an Improvement of $7.4 Million, Adjusted EBITDA of $2.4 Million, an Improvement of $5.0 Million LOS ANGELES, May 15, 2025 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “ …

Expion360 Reports First Quarter 2025 Financial Results
Q1 2025 Revenue Growth of 111% Driven by New Products and Technologies 5th Consecutive Quarter of Robust Revenue Growth Began Shipping e360 Home Energy Storage Solutions REDMOND, Ore., May 15, 2025 (GLOBE NEWSWIRE) -- Expion360 Inc. (Nasdaq: XPON) (“ …

Fold Holdings Inc. (NASDAQ: FLD) Announces First Quarter 2025 Results
Revenue: $7.1 million, 44% YoY increase Bitcoin Treasury Holdings: 1,490 BTC, ~50% increase from Q4 2024 Launched Bitcoin Gift Card with access to network of thousands of retailers New accounts up over 300% YoY and platform volumes up 67% YoY PHOENIX, May …

iPower Reports Fiscal Third Quarter 2025 Results
RANCHO CUCAMONGA, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven ecommerce services provider and online retailer, today announced its financial results for the fiscal third quarter …

SRx Health Solutions Announces First Quarter 2025 Financial Results
EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health …

Dragonfly Energy Reports First Quarter 2025 Results
First Quarter Net Sales and Adjusted EBITDA Above Guidance OEM Net Sales Increased 11% Year-Over-Year Corporate Optimization Program Enhances Operational Efficiencies Guides to Second Quarter Net Sales of Approximately $14.8 Million First Quarter 2025 …

Applied Materials Announces Second Quarter 2025 Results
Revenue $7.10 billion, up 7 percent year over year GAAP gross margin 49.1 percent and non-GAAP gross margin 49.2 percent GAAP operating margin 30.5 percent and non-GAAP operating margin 30.7 percent Record GAAP EPS $2.63 and record non-GAAP EPS $2.39, up …

vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
Ongoing screening in CATT1 Phase 3 trial evaluating cadisegliatin in patients with type 1 diabetes (T1D) Topline Phase 3 data for cadisegliatin expected in 2H 2026 HIGH POINT, N.C., May 15, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a …

Alliance Entertainment Reports Third Quarter Fiscal Year 2025 Results
Delivered $1.9M in net income, a $5.3M year-over-year improvement, showcasing strong execution and margin gains Reduced revolver debt by 25% year-over-year, strengthening balance sheet and liquidity position Direct to Consumer sales reach 35% of gross …

CORRECTING AND REPLACING - Katapult Delivers 15.4% Gross Originations and 10.6% Revenue Growth in the First Quarter, Above Outlook
Expects Growth to Accelerate In Second Quarter Reiterates 2025 Guidance PLANO, Texas, May 15, 2025 (GLOBE NEWSWIRE) -- In the press release issued by Katapult Holdings, Inc. on May 15, 2025, in the gross originations by quarter table, Q4 in FY 2024 should …

Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the …

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected to enter IND-enabling studies in mid …